You are here

  • Home
  • Archive
  • Volume 104, Issue 11
  • Patients with atrial fibrillation and coronary events: are we any closer to coming out from the labyrinth of the various antithrombotic strategies?

Article Text

Article menu
Download PDFPDF
Editorial
Patients with atrial fibrillation and coronary events: are we any closer to coming out from the labyrinth of the various antithrombotic strategies?

https://doi.org/10.1136/heartjnl-2017-312576

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests GP: speaker/consultant/advisory board for Amgen, Sanofi, Bayer, Boehringer-Ingelheim, BMS-Pfizer, Daiichi Sankyo, Astra Zeneca, Sigma-Tau, Malesci, PIAM and MSD.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Arrhythmias and sudden death
      Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation
      Caroline Sindet-Pedersen Laila Staerk Morten Lamberts Thomas Alexander Gerds Jeffrey S Berger Anders Nissen Bonde Jannik Langtved Pallisgaard Morten Lock Hansen Christian Torp-Pedersen Gunnar H Gislason Jonas Bjerring Olesen
      Heart 2017; 104 912-920 Published Online First: 01 Nov 2017. doi: 10.1136/heartjnl-2017-311976